It is possible that differences in receptor selectivity and potency, biased G-protein signaling, systemic and central exposure, or off-target effects are responsible for the different cardiac profiles of these two molecules
Even though Ozempic was originally designed to manage type 2 diabetes, patients reported weight loss benefits, which led to the development of other GLP-1s specifically for the purpose of losing weight
GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), have revolutionized weight loss and type 2 diabetes management
When the body loses weight, particularly adipose (fat) tissue, it loses a layer of natural insulation that helps maintain core body temperature
The timing of your GLP-1 dose matters when fasting
Orentreich, N., Matias, J